Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now?

Is LXRX a good stock to buy? We came across a bullish thesis on Lexicon Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on LXRX. Lexicon Pharmaceuticals, Inc.'s share was trading at $1.8800 as of June 9^th. LXRX’s trailing P/E was 3.74 according to Yahoo Finance.

[caption id="attachment_564482" align="aligncenter" width="750"] Pressmaster/Shutterstock.com[/caption]

Lexicon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on cardiometabolic and neuropathic diseases, anchored by its sotagliflozin dual...